Resolute Advisors’s Merck MRK Stock Holding History

Resolute Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-626	Closed	-$47K	–	402
2021 Q3	$47K	Hold	626	–	–	0.01%	125
2021 Q2	$49K	Sell	626 -30	-5%	-$2.23K	0.01%	85
2021 Q1	$38K	Buy	+656	New	+$48.4K	0.01%	91

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Resolute Advisors's MRK Position: Q4 2021 in Review

Resolute Advisors sold out of Merck (MRK) in Q4 2021, closing a stake of 626 shares — an estimated $47K sold.

Resolute Advisors first reported a position in MRK in Q1 2021 and held it in 3 quarters. The position peaked at $49K in Q2 2021. 2,902 funds tracked by Wall St. Rank hold MRK as of Q4 2021.

Resolute Advisors reported no remaining Merck position as of Q4 2021 after selling out during the quarter.
Resolute Advisors sold 626 Merck shares in Q4 2021, an estimated $47K.
Resolute Advisors first reported a position in Merck in Q1 2021 and held it in 3 quarters.
Resolute Advisors's Merck position peaked at $49K in Q2 2021.
2,902 funds tracked by Wall St. Rank held Merck as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.